Literature DB >> 16049073

Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.

Ngoc Hang Le1, Annemieke van der Wal, Paola van der Bent, Irma S Lantinga-van Leeuwen, Martijn H Breuning, Hans van Dam, Emile de Heer, Dorien J M Peters.   

Abstract

Autosomal dominant polycystic kidney disease is a common inherited disorder that predominantly manifests with the formation of fluid-filled cysts in both kidneys. The disease can be accounted for by a mutation in either the PKD1 or the PKD2 gene. It was demonstrated previously that aberrant expression of the PKD1 gene product, polycystin-1, results in modification of activator protein-1 (AP-1) transcription factor activity in cultured renal epithelial cells. Here, it is reported that activity of the AP-1 components c-Jun, ATF2, and c-Fos is altered in renal cystic tissue of patients with autosomal dominant polycystic kidney disease and of hypomorphic Pkd1 mice with polycystic kidney disease. Data were obtained using immunohistochemical and Western blot analysis. Significant upregulation of Thr71- and Thr69/71-phosphorylated ATF2 and Ser73-phosphorylated c-Jun and increased c-Fos were detected in small cysts and (dilated) ducts and tubules surrounded by fibrotic interstitium. The data indicate that various AP-1 components are constitutively activated in polycystic kidney disease and suggest that aberrant AP-1 activity is relevant for cyst formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049073     DOI: 10.1681/ASN.2004110913

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

Review 1.  Fish and frogs: models for vertebrate cilia signaling.

Authors:  Oliver Wessely; Tomoko Obara
Journal:  Front Biosci       Date:  2008-01-01

2.  The isolated polycystin-1 COOH-terminal can activate or block polycystin-1 signaling.

Authors:  Uma Basavanna; Kimberly M Weber; Qinghua Hu; Roy C Ziegelstein; Gregory G Germino; Michael Sutters
Journal:  Biochem Biophys Res Commun       Date:  2007-05-25       Impact factor: 3.575

Review 3.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

Review 4.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

Review 5.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

6.  Receptor protein tyrosine phosphatases are novel components of a polycystin complex.

Authors:  Catherine A Boucher; Heather H Ward; Ruth L Case; Katie S Thurston; Xiaohong Li; Andrew Needham; Elsa Romero; Deborah Hyink; Seema Qamar; Tamara Roitbak; Samantha Powell; Christopher Ward; Patricia D Wilson; Angela Wandinger-Ness; Richard N Sandford
Journal:  Biochim Biophys Acta       Date:  2010-11-29

Review 7.  Polycystin and calcium signaling in cell death and survival.

Authors:  Fernanda O Lemos; Barbara E Ehrlich
Journal:  Cell Calcium       Date:  2017-05-24       Impact factor: 6.817

8.  Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Authors:  Chun-Liang Lin; Jeng-Yi Wang; Jih-Yang Ko; Yu-Ting Huang; Yu-Hsia Kuo; Feng-Sheng Wang
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

9.  Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.

Authors:  Ruhee Dere; Patricia D Wilson; Richard N Sandford; Cheryl Lyn Walker
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

Review 10.  Advances in monoclonal antibody application in myocarditis.

Authors:  Li-na Han; Shuang He; Yu-tang Wang; Li-ming Yang; Si-yu Liu; Ting Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.